← Leaderboards
Matthew S Freiberg
University Of Pittsburgh At Pittsburgh
$20,071,860
Attributed
$39,693,317
Total exposure
20
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,039,596 · 22
By mechanism
R01$19,767,205 · 7
P01$12,607,300 · 5
U01$10,304,056 · 3
K12$2,652,180 · 2
P60$1,987,375 · 3
U24$1,807,226 · 1
Top collaborators
- Jeffrey H Samet17 shared
- Shirish S Barve14 shared
- Amy Caroline Justice13 shared
- Hilary A. Tindle10 shared
- Priscilla Y. Hsue9 shared
- Evan L Brittain5 shared
- Neil C Chi5 shared
- John Koethe5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- M. Ilyas Kamboh$33,365,358
- Hilary A. Tindle$15,133,646
- Lewis H Kuller$9,420,052
- Akira Sekikawa$16,215,016
- Allison L Kuipers$3,679,571
Others in their field
Top investigators on “Cohort Studies”
- David R. Weir · University Of Michigan At Ann Arbor$408,585,068
- George R Seage · Abt Associates, Inc.$297,656,361
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
- David Heimbrook · Leidos Biomedical Research, Inc.$141,409,002
Research focus
Cohort StudiesCohortRisk FactorsInflammationVeteransAntiretroviral TherapyAlcohol ConsumptionAlcoholsHiv InfectionsBiological MarkersAgingCardiovascular Disorder RiskResourcesCardiovascular DiseasesInflammatoryEventFundingCessation Of LifeFuturePersonsResearch PersonnelParticipantAlcoholic Beverage Heavy DrinkerComorbidity
Grant awards (93)
Southeast Translational Alcohol and HIV Research Center (STAHR Center)$1,785,057
P60 · FY2025 · AA · contact PI
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)$1,435,915
P01 · FY2025 · AA · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$732,435
R01 · FY2025 · HL
Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)$537,839
K12 · FY2025 · DA
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)$440,658
P01 · FY2025 · AA · contact PI
Administrative, Education, and Analytic Support Core$194,597
P01 · FY2025 · AA · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$175,455
R01 · FY2025 · HL
Administrative Core$118,994
P60 · FY2025 · AA · contact PI
GLP-1, Ethanol, and Gut Microbiome dependent Metabolites in HIV (GEM HIV)$83,324
P60 · FY2025 · AA · contact PI
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)$1,774,823
P01 · FY2024 · AA · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$721,691
R01 · FY2024 · HL
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)$535,916
P01 · FY2024 · AA · contact PI
Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)$467,526
K12 · FY2024 · DA
Administrative, Education, and Analytic Support Core$288,193
P01 · FY2024 · AA · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$159,485
R01 · FY2024 · HL
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)$1,737,037
P01 · FY2023 · AA · contact PI
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)$852,599
P01 · FY2023 · AA · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$741,038
R01 · FY2023 · HL
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (Supplement)$435,456
P01 · FY2023 · AA · contact PI
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (Supplement)$215,814
P01 · FY2023 · AA · contact PI
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)$215,814
P01 · FY2023 · AA · contact PI
Administrative, Education, and Analytic Support Core$141,039
P01 · FY2023 · AA · contact PI
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)$1,405,622
P01 · FY2022 · AA · contact PI
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure$759,572
R01 · FY2022 · HL
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)$464,976
P01 · FY2022 · AA · contact PI
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)$346,374
K12 · FY2022 · HL · contact PI
Administrative, Education, and Analytic Support Core$147,597
P01 · FY2022 · AA · contact PI
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)$1,556,555
P01 · FY2021 · AA · contact PI
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure$787,763
R01 · FY2021 · HL
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)$661,394
U01 · FY2021 · AA · contact PI
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)$587,034
P01 · FY2021 · AA · contact PI
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)$400,591
K12 · FY2021 · HL · contact PI
Administrative, Education, and Analytic Support Core$177,655
P01 · FY2021 · AA · contact PI
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$147,070
U01 · FY2021 · AA
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure$790,627
R01 · FY2020 · HL
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)$651,512
U01 · FY2020 · AA · contact PI
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$632,273
U01 · FY2020 · AA
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)$400,052
K12 · FY2020 · HL · contact PI
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$186,966
U01 · FY2020 · AA
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure$871,041
R01 · FY2019 · HL
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans$698,276
R01 · FY2019 · HL
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)$649,329
U01 · FY2019 · AA · contact PI
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$616,539
U01 · FY2019 · AA
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)$400,345
K12 · FY2019 · HL · contact PI
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure$233,692
R01 · FY2019 · HL
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk$199,648
R01 · FY2019 · AA
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)$148,968
U01 · FY2019 · AA · contact PI
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans$711,851
R01 · FY2018 · HL
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)$638,020
U01 · FY2018 · AA · contact PI
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$617,706
U01 · FY2018 · AA
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk$199,648
R01 · FY2018 · AA
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)$99,453
K12 · FY2018 · HL · contact PI
HIV, Depression, and Cardiovascular Risk$712,860
R01 · FY2017 · HL
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans$699,392
R01 · FY2017 · HL
Immune function and the risk of cvd among HIV infected and uninfected veterans$691,563
R01 · FY2017 · HL · contact PI
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)$684,228
U01 · FY2017 · AA · contact PI
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$635,908
U01 · FY2017 · AA
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk$199,648
R01 · FY2017 · AA
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans$756,117
R01 · FY2016 · HL
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians$727,673
U01 · FY2016 · AA
HIV, Depression, and Cardiovascular Risk$721,761
R01 · FY2016 · HL
Immune function and the risk of cvd among HIV infected and uninfected veterans$697,207
R01 · FY2016 · HL · contact PI
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$649,044
U01 · FY2016 · AA
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$99,989
U01 · FY2016 · AA
HIV, Depression, and Cardiovascular Risk$730,659
R01 · FY2015 · HL
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$711,178
U01 · FY2015 · AA
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$455,028
U24 · FY2015 · AA
Immune function and the risk of cvd among HIV infected and uninfected veterans$416,338
R01 · FY2015 · HL · contact PI
Immune function and the risk of cvd among HIV infected and uninfected veterans$289,192
R01 · FY2015 · HL · contact PI
Immune function and the risk of cvd among HIV infected and uninfected veterans$754,326
R01 · FY2014 · HL · contact PI
HIV, Depression, and Cardiovascular Risk$741,170
R01 · FY2014 · HL
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$559,815
U01 · FY2014 · AA
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$425,927
U24 · FY2014 · AA
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$106,460
U01 · FY2014 · AA
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$545,241
U01 · FY2013 · AA
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$416,690
U24 · FY2013 · AA
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort$634,743
U01 · FY2012 · AA
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$509,581
U24 · FY2012 · AA
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$420,959
R01 · FY2012 · HL · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$986,138
R01 · FY2011 · HL · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$274,726
R01 · FY2011 · HL · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$878,370
R01 · FY2010 · HL · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$97,568
R01 · FY2010 · HL · contact PI
Alcohol and Coronary Heart Disease in People with HIV$53,996
K23 · FY2010 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$51,686
R01 · FY2010 · HL · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$835,848
R01 · FY2009 · HL · contact PI
Alcohol and Coronary Heart Disease in People with HIV$179,654
K23 · FY2009 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$50,586
R01 · FY2009 · HL · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$978,869
R01 · FY2008 · HL · contact PI
Alcohol and Coronary Heart Disease in People with HIV$175,995
K23 · FY2008 · AA · contact PI
Alcohol and Coronary Heart Disease in People with HIV$172,262
K23 · FY2007 · AA · contact PI
Alcohol and Coronary Heart Disease in People with HIV$167,850
K23 · FY2006 · AA · contact PI
Alcohol and Coronary Heart Disease in People with HIV$164,497
K23 · FY2005 · AA